Clarification: Hepatitis C Clinical Trial Announcement

Clarification: Hepatitis C Clinical Trial Announcement Sydney, Australia: In yesterday's ASX announcement regarding the initiation of a fourth US site for its hepatitis C clinical trial, Benitec Biopharma Limited (NASDAQ: BNTC; NASDAQ: BNTCW; ASX: BLT) referred to the trial as … Continue reading

AbbVie to Present New Data from Hepatitis C Clinical Development Program at

AbbVie to Present New Data from Hepatitis C Clinical Development Program at … VIEKIRAX and EXVIERA are not recommended as monotherapy and should be used in combination with other medicinal products for the treatment of hepatitis C infection. Pregnancy and … Continue reading